This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Episodic Ataxia Type 2 (disorder)
Information about Episodic Ataxia Type 2 (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Episodic Ataxia Type 2 (disorder)
Most recent studies have shown that Episodic Ataxia Type 2 (disorder) shares some biological mechanisms with ataxia, ataxia-spinocerebellar, atrophy, cerebellar-ataxia, cerebellar-diseases, channelopathies, epilepsy, episodic-ataxia-type-1, familial-hemiplegic-migraine, migraine-disorders, nervous-system-disorder, nervousness, nystagmus, spinocerebellar-ataxia-type-6-(disorder), spinocerebellar-degeneration, vertigo.
Among the many pathways, these few ones have gauged particular interests from scientists studying Episodic Ataxia Type 2 (disorder), and have been seen in publications frequently: Calcium Ion Homeostasis, Cell Death, Dna Amplification, Exocytosis, Hypersensitivity, Immune Response, Ion Homeostasis, Ion Transport, Localization, Neuronal Signal Transduction, Pathogenesis, Reflex, Righting Reflex, Rna Splicing, Secretion, Synaptic Transmission, Transport
Quite a number of genes have been found to play important roles in Episodic Ataxia Type 2 (disorder), such as AMY2A, AURKA, CACNA1A, CACNB4, CALB2, CD69, EPHA3, FLVCR1, GDI1, KCNA1, PSMC4, PSMD1, RPS6, SLC1A3, SLURP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.